Amarin Corp Plc (AMRN)

[pax33]

They aren't looking at mace. Their "base case" is only at mi + cva + maybe chd death with modeled post first events cost. That said they allowed "first events" to stack in the same person in their modelling. It appears they may not be looking at the reduce it events total but based on their own population statistics based on the inclusion parameters of the study. It appears they will apply the hr to this population. This was one of the things amarin tried to get them to change. As an aside they made a very interesting comment. The event rate of afib /bleed was low for both vascepa /placebo. Long story short i have a theory that mineral oil is actually a cardiovascular helpful control and if vascepa was compared to air the rrr would be even better. Won't go into details. I think pyrrh is lurking and will twist it around.